HOME >> BIOLOGY >> NEWS
Johnson & Johnson announces call for nominations

New Brunswick, New Jersey February 15, 2007 Johnson & Johnson today announced that it will accept nominations for The 2008 Dr. Paul Janssen Award for Biomedical Research beginning on June 1, 2007. At that time, nominations will be accepted on-line via the Award website at http://www.pauljanssenaward.com and the winner will be announced in September 2008.

The Dr. Paul Janssen Award for Biomedical Research was established by Johnson & Johnson in 2004 to honor Dr. Paul Janssen, founder of Janssen Pharmaceutica. Dr. Janssen, who was known to his colleagues as Dr. Paul, was one of the most innovative, creative, and productive scientists of the 20th century. The Award is designed to acknowledge a scientist from anywhere in the world whose work has the potential to make a significant transformational contribution toward the improvement of human health. Given every two years, the Award includes a $100,000 cash prize and recipients are chosen by an independent Selection Committee composed of world-leading scientists and clinicians Solomon Snyder, M.D., D.Sc., D.Phil. (Hon. Causa), professor and director of the Department of Neuroscience at Johns Hopkins School of Medicine will chair the Selection Committee for the 2008 Award.

I am very honored to chair the 2008 Dr. Paul Janssen Award Selection Committee, said Dr. Snyder. I expect there will be many excellent scientists nominated for this award and selecting a winner will be a challenging process. However, we are looking forward to finding the scientist whose work and research has the potential to help millions of people while epitomizing the passion, leadership and innovation that defined Dr. Janssen.

Craig C. Mello, Ph. D., a professor of Molecular Medicine at the University of Massachusetts Medical School, Worcester, MA, and an investigator at the Howard Hughes Medical Institute, was named the inaugural recipient of the Award in September 20
'"/>


16-Feb-2007


Page: 1 2

Related biology news :

1. Gladstones Deepak Srivastava receives E. Mead Johnson Award for achievement in pediatrics
2. VIB and Johnson & Johnson set up a new fund
3. Johnson & Johnson names selection committee for Dr. Paul Janssen Award for Biomedical Research
4. HSPHs Walter Willett wins Bristol-Myers Squibb/Mead Johnson Freedom to Discover Award
5. Conservation International and SC Johnson partner again to offset carbon impacts
6. Almac Diagnostics announces pioneering genetic research on ductal carcinoma in situ
7. ESA announces 2007 award recipients
8. President Bush announces 2005 and 2006 Laureates of National Medals of Science and Technology
9. Conservation Leadership Program announces 2007 awardees
10. ACMG Foundation announces 2007-2008 Luminex/ACMGF award recipient
11. Revolutionary global environment fund announces $50M expansion

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Johnson Johnson announces call for nominations

(Date:10/15/2014)... from strains of influenza virus increases with the latest ... complacent that the most substantial threats have been identified, ... arise when a new virus strain – against which ... in the human population. There have been five such ... which – the 1918 Spanish Flu – cost 50 ...
(Date:10/15/2014)... NXT-ID, Inc. (NASDAQ: NXTD and NXTDW) ... growing mobile commerce market releases photos and video of the recent ... October 13 th . Gino Pereira , ... angel investor Mr. Chad A. Verdi rang the bell.  ... his investors and employees "for their work and dedication in bringing ...
(Date:10/14/2014)... of years since T. rex took its ... scientists is breathing life back into dinosaurs using high-powered ... research has important implications for how dinosaurs used their ... sense of smell and cool their brains. , ... student Jason Bourke, lead author of the new study ...
Breaking Biology News(10 mins):Scientists 'must not become complacent' when assessing pandemic threat from flu viruses 2Photo Release: NXT-ID Inc. Rings Opening Bell of the NASDAQ Stock Market October 13th 2Photo Release: NXT-ID Inc. Rings Opening Bell of the NASDAQ Stock Market October 13th 3Dinosaur breathing study shows that noses enhanced smelling and cooled brain 2Dinosaur breathing study shows that noses enhanced smelling and cooled brain 3
(Date:10/25/2014)... (PRWEB) October 24, 2014 The ... the nation’s leading nonprofit authority on the use ... information exchange, announces its appointment of four new ... The workgroup leaders include:, ,     Peter ...     Erik Pupo, Specialist Leader, Deloitte Consulting LLP ...
(Date:10/25/2014)... (PRWEB) October 24, 2014 SonaCare ... focused ultrasound (HIFU) technology, announced that its Board ... as Chief Executive Officer, President and member of ... Dr. Carol will take-on expanded responsibilities within the ... as well as overseeing commercialization, manufacturing and finance. ...
(Date:10/25/2014)... , October 24, 2014 ... clinical-stage pharmaceutical company focused on the development of oral ... Nadav Kidron will present at FireRock Capital,s ... Capital,s Annual Micro-Cap Conference ,Date: Tuesday, October 28, 2014 ... New York City , ...
(Date:10/25/2014)... -- Investor-Edge has initiated coverage on the ... Vertex Pharmaceuticals Inc. (NASDAQ: VRTX ), Alexion ... Inc. (NASDAQ: PPHM ), and StemCells Inc. ... be accessed at: http://investor-edge.com/register . The ... a positive note as the Dow Jones Industrial Average ...
Breaking Biology Technology:WEDI Appoints Four New Security and Privacy Workgroup Co-chairs 2SonaCare Medical Board of Directors Appoints Dr. Mark Carol as CEO and President 2SonaCare Medical Board of Directors Appoints Dr. Mark Carol as CEO and President 3Oramed to Present at the FireRock Annual Micro-Cap Conference 2Oramed to Present at the FireRock Annual Micro-Cap Conference 3Biotech Stocks Technical Data - CytRx, Vertex Pharma, Alexion Pharma, Peregrine Pharma, and StemCells 2Biotech Stocks Technical Data - CytRx, Vertex Pharma, Alexion Pharma, Peregrine Pharma, and StemCells 3Biotech Stocks Technical Data - CytRx, Vertex Pharma, Alexion Pharma, Peregrine Pharma, and StemCells 4Biotech Stocks Technical Data - CytRx, Vertex Pharma, Alexion Pharma, Peregrine Pharma, and StemCells 5
Cached News: